-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
The Total Return for Joinn Laboratories(China)Co.Ltd (SHSE:603127) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
The Total Return for Joinn Laboratories(China)Co.Ltd (SHSE:603127) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
It might be of some concern to shareholders to see the Joinn Laboratories(China)Co.,Ltd. (SHSE:603127) share price down 22% in the last month. But that doesn't change the fact that the returns over the last half decade have been spectacular. To be precise, the stock price is 465% higher than it was five years ago, a wonderful performance by any measure. So we don't think the recent decline in the share price means its story is a sad one. But the real question is whether the business fundamentals can improve over the long term. While the long term returns are impressive, we do have some sympathy for those who bought more recently, given the 50% drop, in the last year.
Since the long term performance has been good but there's been a recent pullback of 4.5%, let's check if the fundamentals match the share price.
View our latest analysis for Joinn Laboratories(China)Co.Ltd
There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
During five years of share price growth, Joinn Laboratories(China)Co.Ltd achieved compound earnings per share (EPS) growth of 46% per year. This EPS growth is reasonably close to the 41% average annual increase in the share price. This indicates that investor sentiment towards the company has not changed a great deal. Rather, the share price has approximately tracked EPS growth.
You can see below how EPS has changed over time (discover the exact values by clicking on the image).
SHSE:603127 Earnings Per Share Growth September 21st 2022We know that Joinn Laboratories(China)Co.Ltd has improved its bottom line over the last three years, but what does the future have in store? This free interactive report on Joinn Laboratories(China)Co.Ltd's balance sheet strength is a great place to start, if you want to investigate the stock further.
What About Dividends?
It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for Joinn Laboratories(China)Co.Ltd the TSR over the last 5 years was 473%, which is better than the share price return mentioned above. And there's no prize for guessing that the dividend payments largely explain the divergence!
A Different Perspective
While the broader market lost about 16% in the twelve months, Joinn Laboratories(China)Co.Ltd shareholders did even worse, losing 50% (even including dividends). However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Longer term investors wouldn't be so upset, since they would have made 42%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Joinn Laboratories(China)Co.Ltd better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Joinn Laboratories(China)Co.Ltd , and understanding them should be part of your investment process.
If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CN exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
股東可能會有一些擔憂,因為他們看到卓恩實驗室(中國)有限公司(上海證券交易所:603127)上個月股價下跌22%。但這並不能改變這樣一個事實,即過去五年的回報一直很可觀。準確地説,該公司股價比五年前高出465%,無論以什麼標準衡量,這都是一個了不起的表現。因此,我們不認為最近股價的下跌意味着它的故事是可悲的。但真正的問題是,業務基本面能否在長期內得到改善。雖然長期回報令人印象深刻,但考慮到去年下跌了50%,我們確實對最近買入的人表示了一些同情。
由於長期表現良好,但最近出現了4.5%的回調,讓我們看看基本面是否與股價匹配。
查看我們對卓恩實驗室(中國)有限公司的最新分析
不可否認,市場有時是有效的,但價格並不總是反映潛在的商業表現。評估圍繞一家公司的情緒變化的一個有缺陷但合理的方法是將每股收益(EPS)與股價進行比較。
在五年的股價增長中,卓恩實驗室(中國)有限公司實現了每股收益(EPS)每年46%的複合增長。這一每股收益增長相當接近該公司股價年均41%的漲幅。這表明投資者對該公司的情緒沒有太大變化。相反,該公司股價已大致追隨每股收益的增長。
您可以在下面看到EPS是如何隨着時間的推移而變化的(通過單擊圖像來了解確切的值)。
上海證交所:2022年9月21日每股收益增長603127我們知道,卓恩實驗室(中國)有限公司在過去三年裏提高了利潤,但未來會是什麼樣子呢?這免費如果你想進一步調查該股,有關卓恩實驗室(中國)有限公司資產負債表實力的互動報告是一個很好的起點。
那股息呢?
重要的是要考慮任何給定股票的總股東回報以及股價回報。雖然股價回報只反映股價的變動,但TSR包括股息的價值(假設股息再投資),以及任何折價集資或分拆所帶來的利益。公平地説,TSR為支付股息的股票提供了更完整的圖景。我們注意到,卓恩實驗室(中國)有限公司過去5年的總回報率為473%,好於上述股價回報率。而且,猜測股息支付在很大程度上解釋了這種差異是沒有好處的!
不同的視角
雖然大盤在過去12個月裏下跌了約16%,但仲量聯行(中國)有限公司的股東表現更糟,損失了50%(甚至包括股息)。然而,這可能只是因為股價受到了更廣泛的市場緊張情緒的影響。也許有必要關注基本面,以防出現良機。較長期的投資者不會如此沮喪,因為他們在五年內每年的回報率將達到42%。最近的拋售可能是一個機會,因此可能值得查看基本面數據,以尋找長期增長趨勢的跡象。跟蹤股價的長期表現總是很有趣的。但為了更好地瞭解卓恩實驗室(中國)有限公司,我們還需要考慮許多其他因素。例如,考慮一下無處不在的投資風險幽靈。我們已經確定了1個警告信號與卓恩實驗室(中國)有限公司合作,瞭解他們應該是你投資過程的一部分。
如果你像我一樣,你會的不想懷念這一切嗎?免費內部人士正在收購的成長型公司名單。
請注意,本文引用的市場回報反映了目前在CN交易所交易的股票的市場加權平均回報。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧